Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2002 6
2003 6
2004 8
2005 12
2006 10
2007 8
2008 12
2009 14
2010 15
2011 19
2012 22
2013 34
2014 44
2015 45
2016 52
2017 54
2018 60
2019 80
2020 97
2021 77
2022 82
2023 75
2024 101
2025 141
2026 44

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

996 results

Results by year

Filters applied: . Clear all
Page 1
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
You R, Liu YP, Xie YL, Lin C, Duan CY, Chen DP, Pan Y, Qi B, Zou X, Guo L, Cao JY, Zhang YN, Wang ZQ, Liu YL, Ouyang YF, Wen K, Yang Q, Xie RQ, Li HF, Duan XT, Ding X, Peng L, Chen SY, Liang JL, Feng ZK, Xia TL, Xie RL, Jiang R, Gu CM, Liu RZ, Sun R, Yang X, Liu LZ, Ling L, Liu Q, Ng WT, Hua YJ, Huang PY, Chen MY. You R, et al. Among authors: guo l. Lancet. 2023 Mar 18;401(10380):917-927. doi: 10.1016/S0140-6736(23)00269-6. Epub 2023 Feb 23. Lancet. 2023. PMID: 36842439 Clinical Trial.
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial.
DIAMOND Study Group; Xu C, Liang XY, Huang XQ, Jin F, Yang KY, Hu GY, Zhu XD, Wang Y, Huang Y, Zhang N, Hu DS, Guo L, Zou GR, Chen XZ, Xiao SW, Li JG, Shen LF, Li YY, Huang J, Long GX, Li L, Huang L, She LJ, Wu Y, Zeng WH, Qiang MY, Liu WX, Su Y, Tang LL, Xie FY, Han F, Lu LX, Xiang YQ, Mao YP, Li WF, Liu X, Yang Q, Zhou GQ, Guo R, Ouyang PY, Wang XH, Chen L, Liu LT, Lin L, Li JB, Lin AH, Zhao HY, Hong SB, Jie YS, Huang HL, Tang XH, Zeng YC, Yun JP, Zang SB, Du ZM, Ye ZL, Liu LZ, Tian L, Li HJ, Peng YL, Liu N, Li YQ, Liang YL, Wei HM, Chen YP, Zhang Y, Du XJ, Lv JW, Sun Y, Ma J. DIAMOND Study Group, et al. Among authors: guo l. JAMA. 2025 Sep 16;334(11):973-983. doi: 10.1001/jama.2025.13205. JAMA. 2025. PMID: 40839372 Free PMC article. Clinical Trial.
Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemic.
Zhao C, Zhang T, Guo L, Sun S, Miao Y, Yung CF, Tomlinson J, Stolyarov K, Shchomak Z, Poovorawan Y, Nokes DJ, Muñoz-Almagro C, Mandelboim M, Keck JW, Langley JM, Heikkinen T, Deng J, Colson P, Chakhunashvili G, Caballero MT, Bont L, Feikin DR, Nair H, Wang X, Li Y; Respiratory Virus Global Epidemiology Network. Zhao C, et al. Among authors: guo l. Nat Commun. 2025 Feb 13;16(1):1610. doi: 10.1038/s41467-025-56776-z. Nat Commun. 2025. PMID: 39948338 Free PMC article.
Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal Carcinoma.
Huang PY, Chen XY, Ding X, Guo L, Mo HY, Zou X, Duan CY, Ling L, You R, Yang X, Liu YP, Xie YL, Zhang YN, Cao JY, Liu SH, Wang ZM, Yang Q, Lin C, Chen SY, Ouyang YF, Liu YL, Wen K, Duan XT, Jiang R, Liu RZ, Yu T, Qiu F, Hua YJ, Cao KJ, Luo DH, Chen MY. Huang PY, et al. Among authors: guo l. NEJM Evid. 2025 May;4(5):EVIDoa2400214. doi: 10.1056/EVIDoa2400214. Epub 2025 Apr 22. NEJM Evid. 2025. PMID: 40261119 Clinical Trial.
Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma: A Phase 3 Randomized Clinical Trial.
Guo SS, Li XY, Liu LT, Jia GD, Liu SL, Sun XS, Luo DH, Yang JH, Xie SY, Li YF, Lv X, Xiang YQ, Xia WX, Sun R, Liu Q, Li JB, Wang P, Yang Q, Wang L, Wen DX, Jin J, Lin JY, Mo HY, Guo L, Zhao C, Guo X, Chen QY, Tang LQ, Mai HQ. Guo SS, et al. Among authors: guo l. JAMA Oncol. 2025 Aug 1;11(8):864-873. doi: 10.1001/jamaoncol.2025.1597. JAMA Oncol. 2025. PMID: 40531520 Clinical Trial.
996 results